SHUXING ZHANG to Humans
This is a "connection" page, showing publications SHUXING ZHANG has written about Humans.
Connection Strength
0.131
-
Editorial: The Elephant in the Room: Targeting Ras for Therapeutic Development. Mini Rev Med Chem. 2016; 16(5):343-4.
Score: 0.010
-
Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol. 2013 Jan; 6(1):41-7.
Score: 0.008
-
A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors. Pac Symp Biocomput. 2013; 29-40.
Score: 0.008
-
Quantitative prediction of glucuronidation in humans using the in vitro- in vivo extrapolation approach. Curr Top Med Chem. 2013; 13(11):1343-52.
Score: 0.008
-
Novel insights of structure-based modeling for RNA-targeted drug discovery. J Chem Inf Model. 2012 Oct 22; 52(10):2741-53.
Score: 0.008
-
In silico lead identification and optimization for drug discovery. Curr Pharm Des. 2012; 18(9):1171-2.
Score: 0.008
-
From laptop to benchtop to bedside: structure-based drug design on protein targets. Curr Pharm Des. 2012; 18(9):1217-39.
Score: 0.008
-
Computational prediction of protein hot spot residues. Curr Pharm Des. 2012; 18(9):1255-65.
Score: 0.008
-
A critical assessment of combined ligand- and structure-based approaches to HERG channel blocker modeling. J Chem Inf Model. 2011 Nov 28; 51(11):2948-60.
Score: 0.008
-
Recent development of anticancer therapeutics targeting Akt. Recent Pat Anticancer Drug Discov. 2011 Jan; 6(1):146-59.
Score: 0.007
-
Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther. 2010 Jun; 87(6):754-8.
Score: 0.007
-
Molecular networks in drug discovery. Crit Rev Biomed Eng. 2010; 38(2):143-56.
Score: 0.007
-
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorg Med Chem. 2009 Oct 01; 17(19):6983-92.
Score: 0.007
-
Small molecule compounds targeting miRNAs for cancer therapy. Adv Drug Deliv Rev. 2015 Jan; 81:104-16.
Score: 0.002
-
Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein. Cancer Res. 2014 Jun 01; 74(11):3127-36.
Score: 0.002
-
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell. 2013 Aug 01; 154(3):556-68.
Score: 0.002
-
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci U S A. 2012 Aug 07; 109(32):13016-21.
Score: 0.002
-
Accurate prediction of glucuronidation of structurally diverse phenolics by human UGT1A9 using combined experimental and in silico approaches. Pharm Res. 2012 Jun; 29(6):1544-61.
Score: 0.002
-
SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies. Mol Pharm. 2012 Apr 02; 9(4):862-73.
Score: 0.002
-
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 08; 104(3):228-39.
Score: 0.002
-
3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in I?Ba kinase, leading to down-regulation of nuclear factor-?B (NF-?B)-regulated gene products and sensitization of tumor cells. J Biol Chem. 2012 Jan 02; 287(1):245-256.
Score: 0.002
-
Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1. Mol Pharm. 2011 Dec 05; 8(6):2379-89.
Score: 0.002
-
First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci. 2011 Sep; 100(9):3655-81.
Score: 0.002
-
Development of sulfonamide AKT PH domain inhibitors. Bioorg Med Chem. 2011 Mar 15; 19(6):2046-54.
Score: 0.002
-
Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model. J Pharmacol Exp Ther. 2011 Feb; 336(2):403-13.
Score: 0.002
-
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. Mol Cancer Ther. 2010 Mar; 9(3):706-17.
Score: 0.002
-
Discovery of a novel class of AKT pleckstrin homology domain inhibitors. Mol Cancer Ther. 2008 Sep; 7(9):2621-32.
Score: 0.002
-
Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol. 2007 Dec; 19(6):618-27.
Score: 0.001
-
Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models. Metab Brain Dis. 1996 Mar; 11(1):19-37.
Score: 0.001